Location: San Clemente, CA
Technology: VertiFlex develops minimally invasive products for the treatment of lumbar spinal stenosis. Its Superion Interspinous Spacer system was approved by the FDA last year and is "designed to deliver the implant through a single, small incision in the patient's back," and is closed with a single suture, according to the company's website. Given that cost effectiveness of new technology is an overwhelming concern, it may be appealing to doctors that the procedure can apparently be performed under local anesthesia on an outpatient basis instead of traditional invasive, decompression surgery to relieve patients.
Money Raised: $26.8 million
Investors: Alta Partners, Thomas McNerney and Partners, and an undisclosed firm
Illustration of Superion Interspinous Spacer courtesy of VertiFlex
Learn more about cutting-edge medical devices at MD&M East, June 14-15, 2016 in New York City.